Trump demands pharma CEOs lower drug prices within 60 days
Trump shared the letters sent to major pharmaceutical firms including Regeneron (NASDAQ:REGN), Merck (NSE:PROR), AstraZeneca (NASDAQ:AZN), GSK, Pfizer (NYSE:PFE), Novo Nordisk (NYSE:NVO), Amgen (NASDAQ:AMGN), Bristol-Myers, AbbVie (NYSE:ABBV), Novartis (SIX:NOVN), Johnson & Johnson (NYSE:JNJ), Genentech, EMD Serono, Boehringer Ingelheim, and Gilead (NASDAQ:GILD) on his Truth Social platform.
In the letters, Trump referenced his May 12, 2025 Executive Order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients," which aims to ensure Americans pay the same prices for medications as other developed nations. The President noted that brand name drug prices in the U.S. are currently up to three times higher on average than in other countries for identical medicines.
Trump called on pharmaceutical manufacturers to take four specific actions within the next 60 days, by September 29, 2025:
First, extend Most-Favored-Nation (MFN) pricing to Medicaid patients for their full portfolio of existing drugs.
Second, guarantee MFN pricing for newly launched drugs for Medicare, Medicaid, and commercial payers both at launch and going forward.
Third, return increased revenues from abroad to American patients and taxpayers, with Trump stating that U.S. trade policy would support manufacturers in negotiating harder with "foreign freeloading nations."
Fourth, participate in Direct-to-Consumer and Direct-to-Business distribution models for high-volume, high-rebate prescription drugs to ensure all Americans receive the same low MFN prices.
The President warned pharmaceutical companies that if they refuse to cooperate, his administration would "deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices."
Trump stated that his team, including Secretary Kennedy and Administrator Oz, are ready to implement these terms and expect immediate good faith engagement from the companies.
Related articles
Trump demands pharma CEOs lower drug prices within 60 days
Apollo economist warns: AI bubble now bigger than 1990s tech mania
If Powell goes, does Fed trust go with him?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
International Paper (IP) Extends 4-Day Drop as Q2 Earnings Dampen Sentiment
We recently published . International Paper Company (NYSE:IP) is one of the worst-performing stocks on Thursday. International Paper extended its losses for a fourth straight day on Thursday, slashing 12.85 percent to close at $46.74 apiece after reporting a disappointing earnings performance in the second quarter of the year. In the first six months of the year, International Paper Company (NYSE:IP) fell to a net loss of $30 million from a $554 million net income in the same period last year. Meanwhile, it registered a $75-million net income in the second quarter alone, albeit an 85-percent drop from $498 million in the same period last year. Net sales for the six-month period, however, increased by 35 percent to $12.67 billion from $9.35 billion year-on-year, while net sales for the quarter grew by 43 percent to $6.77 billion from $4.73 billion. 'Our second quarter results reflect a full quarter of our combined International Paper and DS Smith packaging businesses, as we effectively implement 80/20 strategies,' said International Paper Company (NYSE:IP) CEO Andy Silvernail. 'In Packaging Solutions North America, our commercial efforts are driving increased revenue, and we experienced seasonally higher volumes and a stable demand environment. However, margins slipped as we continue to face cost headwinds, and we executed a heavy outage schedule. In Europe, demand remained soft and there was a significant increase in depreciation and amortization expense resulting from our acquisition,' he added. Copyright: zefart / 123RF Stock Photo Looking ahead, International Paper Company (NYSE:IP) posted a more optimistic outlook for the third quarter, but failed to provide target figures on key metrics. While we acknowledge the potential of IP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Apple and Amazon earnings should end tech stock bubble fears: Opening Bid top takeaway
A weak jobs report with a side of hot tech earnings and fresh tariffs. The US economy created 73,000 jobs in July, falling short of estimates for 100,000. And there were large downward revisions to May and June jobs numbers! The unemployment rate held steady at 4.2%. Investors are likely to wonder if the Trump administration's tariff policy — including new levies on goods from Canada and other top trading partners today — is beginning to weigh on hiring plans and the economy. Queue those Trump rate-cut posts on Truth Social. The economic read comes on the heels of strong earnings from Apple (AAPL) and Amazon (AMZN) last night. The duo capped an impressive earnings week for large caps, with Meta (META) and Microsoft (MSFT) being the other standouts. Even second-tier Big Tech names in Roblox (RBLX) have crushed expectations (watch CEO Dave Baszucki's interview above). Most importantly, Amazon, Apple, Alphabet (GOOG, GOOGL), Microsoft, and Meta all put to bed one fear: Lofty valuations supported by hopes for AI-driven growth may not be lofty enough. Zoom in: Large-cap tech earnings quiet the naysayers Not only did Amazon, Apple, Meta, and Microsoft show strong growth throughout their giant businesses, but execs also conveyed that AI is unlocking new avenues of growth for the quarter to come. Their bottom lines also easily eclipsed Wall Street forecasts. Reports were generally embraced (save for Amazon, where investors opted to lock in on an OK outlook rather than a blowout outlook). "As the main engine of US equity profitability for the last few years, 2Q25 results from Alphabet, Meta and Microsoft suggest that growth momentum is intact," Barclays strategist Venu Krishna said. It's a point well taken. Apple's services growth tallied 13% last quarter and is expected to increase at a similar pace in the current quarter. Quarterly iPhone sales increased 13% from the prior year and improved in every geographic market. The company had the saddest story to tell on the AI front, but CEO Tim Cook still did enough on the earnings call to temporarily ratchet down worries that Apple will be a nonentity in AI. The company has spent $15.5 billion in capital expenditures in the first half of the year, up from $11 billion a year ago — underscoring its AI investment roadmap. AI rollouts by big companies continue to feed Amazon's lucrative AWS cloud business. Second quarter sales for AWS rose 17.5% from last year, accelerating from a 16.9% growth rate in the first quarter. Amazon CEO Andy Jassy said on the earnings call that demand for AWS is outstripping supply. "We highlight several potential catalysts in the intermediate-term that could possibly offset some near-term uncertainty, including (1) more meaningful improvements in cost to serve driven by deeper automation and robotics, (2) commercialization of new AI capabilities in Alexa, (3) monetization of Project Kuiper which could begin late this year, and (4) an expected increase in Prime Subscription prices in 2026," Wedbush analyst Dan Ives said. The same vibe was seen at Microsoft as sales at the Azure cloud business accelerated 4% sequentially. Azure's growth "further validates Microsoft's share gains and leadership in monetizing AI," Citi analyst Tyler Radke said. Then there was the report of the week out of Meta. On top of a 22% sales increase, the company signaled that the good times will keep on rolling as it plows deeper into artificial intelligence. AI investments are beginning to pay off in terms of driving more sales growth, execs told the Street. Perhaps more important than the sales increase is that operating profit margins rose despite megaspending on AI projects. KeyBanc analyst Justin Patterson said, "Meta's 2Q results reinforced that AI is driving positive impacts on engagement and advertising, which enables Meta to invest more in AI capacity." Given the strength, one has to wonder if these stocks are actually cheap despite their above-market multiples. The answer to that may be yes — it's hard to see what squashes their financial momentum over the next 12 Sozzi is Yahoo Finance's Executive Editor and a member of Yahoo Finance's editorial leadership team. Follow Sozzi on X @BrianSozzi, Instagram, and LinkedIn. Tips on stories? Email Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Comstock (CRK) Swings to Profitability in Q2, But Analyst Not Impressed
We recently published . Comstock Resources, Inc. (NYSE:CRK) is one of the worst-performing stocks on Thursday. Comstock Resources fell by 14.05 percent on Thursday to end at $17.87 apiece as investors took path from a pessimistic outlook and a lower price target from an investment firm. In a market note, UBS further downgraded Comstock Resources, Inc. (NYSE:CRK) to a 'sell' recommendation after lowering it to 'neutral' on July 10. It also reduced its price target to $18 from $20 previously. According to UBS, Comstock Resources, Inc. (NYSE:CRK) currently faces potential downside risks, including lower natural gas prices, underscoring an approximately 0.5 Bcfpd oversupplied balance that could cause risks due to its leverage position and low free cash flow generation. In other news, Comstock Resources, Inc. (NYSE:CRK) swung to an attributable net income of $125 million from a $126 million net loss in the same period last year. Total revenues surged by 90 percent to $270 million from $246.8 million year-on-year. While we acknowledge the potential of CRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
